Listed by the USPTO as TICHY, JENNIFER M.H.
Tech Center 3700 • Art Units: 1653 3791
This examiner grants 65% of resolved cases
TICHY, JENNIFER M.H. examines in USPTO tech center 3700 and art unit 1653. The record contains 618 resolved cases, with an allowance rate of 64.6% and a median of 1088 days to allowance. The interview lift is 34.4%, indicating that interviews are associated with a meaningful improvement in allowance outcomes in the available record.
The principal companies are The Fynder Group, Inc., The Trustees of the University of Pennsylvania, and Osaka University. The firms most frequently listed are BAKER BOTTS L.L.P., FOLEY & LARDNER LLP, and WENDEROTH, LIND & PONACK, L.L.P. The profile is relevant to practitioners handling university, research, and technology matters who are considering interviews as part of a broader prosecution plan.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17906279 | DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITY | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 17816924 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18018383 | NEW AGROCHEMICAL FORMULATIONS FOR FUSARICIDIN PRODUCING BACTERIA | Non-Final OA | BASF SE |
| 18014194 | AUTOMATED SAMPLE PREPARATION PLATFORM FOR CELLULAR ANALYSIS | Final Rejection | Beckman Coulter, Inc. |
| 18583042 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | Non-Final OA | NewLeaf Symbiotics, Inc. |
| 18693429 | BACTERIOLYSIS METHOD AND BACTERIA DETECTION METHOD | Non-Final OA | ASAHI KASEI KABUSHIKI KAISHA |
| 18006413 | IN VIVO SCREENING ARRAY | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 18115402 | Wearable Engineered Human Skin and Systems and Methods for Making the Same | Final Rejection | The Trustees of Columbia University in the City of New York |
| 18739556 | CELL SAMPLE MEASUREMENT METHOD AND CELL SAMPLE MEASUREMENT APPARATUS | Non-Final OA | Hamamatsu Photonics K.K. |
| 16755226 | METHODS FOR INCREASING THE TOLERANCE OF MICROBIAL CELLS TOWARDS ANTHRANILIC ACID BY LIMITING THE AMOUNT OF AMMONIA IN THE CULTURE MEDIUM | Final Rejection | Covestro Deutschland AG |
| 17783097 | Freeze-Dried Preparations Comprising Megakaryocytes and Platelets | Final Rejection | Kyoto University |
| 17905088 | DIBORIDE MICROPATTERNED SURFACES FOR CELL CULTURE | Non-Final OA | University of Houston System |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18282450 | PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN | Non-Final OA | Osaka University |
| 17386776 | DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME | Final Rejection | Osaka University |
| 18162777 | CELL LINES, SYSTEMS, KITS, AND METHODS FOR DETERMINING THE SPECIFICITY AND/OR POTENCY OF CERAMIDASE INHIBITORS | Non-Final OA | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. |
| 17906464 | CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF VIRAL INFECTIONS | Final Rejection | Capricor, Inc. |
| 18286954 | COMPOSITION CONTAINING MESENCHYMAL STEM CELL AND VASCULAR ENDOTHELIAL PROGENITOR CELL AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCCLUSIVE VASCULAR DISEASE OR COMPLICATION THEREOF | Final Rejection | ELPHIS CELL THERAPEUTICS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.6% of resolved applications examined by Jennifer M.H. Tichy were allowed (618 resolved cases), compared with 23.5% across Art Unit 1653 over the last five years.
This examiner's interview lift is +34.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jennifer M.H. Tichy took 1,088 days on average from filing to allowance.
Jennifer M.H. Tichy examines applications in Art Unit 1653 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
